KR900001548B1 - 피라졸로 피리딘 유도체의 제조방법 - Google Patents

피라졸로 피리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR900001548B1
KR900001548B1 KR1019840001544A KR840001544A KR900001548B1 KR 900001548 B1 KR900001548 B1 KR 900001548B1 KR 1019840001544 A KR1019840001544 A KR 1019840001544A KR 840001544 A KR840001544 A KR 840001544A KR 900001548 B1 KR900001548 B1 KR 900001548B1
Authority
KR
South Korea
Prior art keywords
compound
formula
group
lower alkyl
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019840001544A
Other languages
English (en)
Korean (ko)
Other versions
KR840008154A (ko
Inventor
쓰또무 이리구라
세이고 스즈에
히데오 오오꾸보
카쓰야 이와노
Original Assignee
쿄린 세이야꾸 가부시끼가이샤
하기하리 히데시
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쿄린 세이야꾸 가부시끼가이샤, 하기하리 히데시 filed Critical 쿄린 세이야꾸 가부시끼가이샤
Publication of KR840008154A publication Critical patent/KR840008154A/ko
Application granted granted Critical
Publication of KR900001548B1 publication Critical patent/KR900001548B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019840001544A 1983-03-26 1984-03-26 피라졸로 피리딘 유도체의 제조방법 Expired KR900001548B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP51053 1983-03-26
JP58051053A JPS59204191A (ja) 1983-03-26 1983-03-26 ピラゾロピリジン誘導体、その製法及びそれを含有する治療剤

Publications (2)

Publication Number Publication Date
KR840008154A KR840008154A (ko) 1984-12-13
KR900001548B1 true KR900001548B1 (ko) 1990-03-12

Family

ID=12876060

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840001544A Expired KR900001548B1 (ko) 1983-03-26 1984-03-26 피라졸로 피리딘 유도체의 제조방법

Country Status (10)

Country Link
US (1) US4559402A (cg-RX-API-DMAC10.html)
EP (1) EP0121197B1 (cg-RX-API-DMAC10.html)
JP (1) JPS59204191A (cg-RX-API-DMAC10.html)
KR (1) KR900001548B1 (cg-RX-API-DMAC10.html)
CA (1) CA1246575A (cg-RX-API-DMAC10.html)
DE (1) DE3461377D1 (cg-RX-API-DMAC10.html)
DK (1) DK154218C (cg-RX-API-DMAC10.html)
ES (1) ES8602785A1 (cg-RX-API-DMAC10.html)
HU (1) HU189844B (cg-RX-API-DMAC10.html)
NO (1) NO162964C (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2177601A (en) * 1985-07-11 1987-01-28 Shell Int Research Use of pyridine and pyridazine derivatives as fungacides
FR2594438B1 (fr) * 1986-02-14 1990-01-26 Labaz Sanofi Nv Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
US5179103A (en) * 1987-06-15 1993-01-12 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
FR2687675B1 (fr) * 1992-01-31 1997-04-18 Roussel Uclaf Nouveaux derives bicycliques de la pyridine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097483A (en) * 1974-11-01 1978-06-27 Kyorin Pharmaceutical Co., Ltd. Pyrazolo 1,5-a!pyridines
JPS5154583A (en) * 1974-11-01 1976-05-13 Kyorin Seiyaku Kk Shinkipirazoro * 1 55a * pirijinjudotaino seizoho

Also Published As

Publication number Publication date
DE3461377D1 (en) 1987-01-08
NO162964C (no) 1990-03-14
DK154218C (da) 1989-03-13
ES530989A0 (es) 1985-12-01
KR840008154A (ko) 1984-12-13
HU189844B (en) 1986-08-28
DK165184D0 (da) 1984-03-23
DK154218B (da) 1988-10-24
HUT34026A (en) 1985-01-28
JPS59204191A (ja) 1984-11-19
ES8602785A1 (es) 1985-12-01
US4559402A (en) 1985-12-17
NO162964B (no) 1989-12-04
NO841109L (no) 1984-09-27
CA1246575A (en) 1988-12-13
JPH0420916B2 (cg-RX-API-DMAC10.html) 1992-04-07
DK165184A (da) 1984-09-27
EP0121197A1 (en) 1984-10-10
EP0121197B1 (en) 1986-11-20

Similar Documents

Publication Publication Date Title
US4282233A (en) Antihistaminic 11-(4-piperidylidene)-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridines
US5034401A (en) Derivatives of (1-hydroxy-2-piperidylalkyl-indol-2-ones, 2-quinolinones, 2-benzo(B)azapinones, benzimidazol-2-ones, and quinazolin-2-ones, their preparation and their application in therapeutics
US4714762A (en) Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof
US3993656A (en) 1,8-Naphthyridine compounds
JP3122792B2 (ja) 新規な活性化合物
JPS6013788A (ja) 新規なクマリン誘導体
EP0198456A2 (en) 1,7-Naphthyridine derivatives and medicinal preparations containing same
DE2845220A1 (de) Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie
EP0053789A1 (en) 2-Pyridinecarboxamide derivative, process for preparing same and pharmaceutical composition, useful as an anti-allergic agent
JPH0377867A (ja) 新規オキサゾロピリジン誘導体
EP0121197B1 (en) Pyrazolopyridine derivatives, therapeutic compositions comprising same, and process thereof
US4709031A (en) Imidazothiadiazolealkylene carboxylic acids
US3803161A (en) 2-substituted-4,5,6,7-tetrahydrobenzothiazole-4-carboxylic acids and their alkyl esters
CS226901B1 (en) Thiazoloisoquinoline derivatives
US2960504A (en) 1-hydrazino, 4-pyridyl methyl-phthalazines
PT86695B (pt) Processo para a preparacao de tetra-hidro-pirido{3',4':4,5}pirrolo{2,3-c}quinolinas, dos seus intermediarios
FR2508457A1 (fr) Pyrrolo(2,1-b)quinazolines et pyrido(2,1-b)quinazolines substituees, leur preparation et leurs utilisations therapeutiques
US4851411A (en) 5-monoaryl as.-triazin-3-ones substituted in 2-position, and their use as medicaments
JPH02200685A (ja) 新規なインドール誘導体
EP0216323A2 (en) Quinolonecarboxylic acid derivatives and their preparation
US3773746A (en) 1,1'-azo bis(1h-imidazo(1,2-a)pyridinium dibromide compounds
HU192728B (en) Process for producing 4-oxo-pyrido/2,3-d/pyrimidine derivatives and pharmaceutical compositions containing them
US5190960A (en) Medicinal oxazolopyridine compounds
US3468889A (en) O-and/or s-nicotinoyl diacylthiamines and acylation process for preparing the same
US3849557A (en) Pharmaceutical compositions containing 1,1-azo bis-(1h-imidazo(1,2-a)pyridinium)dibromide compounds and the use thereof

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

FPAY Annual fee payment

Payment date: 20030206

Year of fee payment: 14

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 14

EXPY Expiration of term
PC1801 Expiration of term

St.27 status event code: N-4-6-H10-H14-oth-PC1801

Not in force date: 20040327

Ip right cessation event data comment text: Termination Category : EXPIRATION_OF_DURATION

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000